检索结果-南通市图书馆

CACA guidelines for holistic integrative management of rectal cancer

在线全文

学校读者我要写书评

暂无评论

Holistic Integrative Oncology 2023年第1期2卷 1-31页

作者： Committee of Colorectal Cancer Society chinese Anti-Cancer Association Guiyu Wang Daiming Fan Jin Gu Kefeng Ding Xuedong Fang Lin Shen Zhongfa Xu Jianmin Xu Jianchun Cai Lianming Cai Sanjun Cai Gong Chen Jiansi Chen Longwei Cheng Yong Cheng Pan Chi Binbin Cui Guanghai Dai Chuangang Fu Yanhong Gu Guodong He Junhong Hu Jing Huang Rui Huang Zhongcheng Huang Zheng Jiang Zhigang Jie Haixing Ju Hai Li Jian Li Jun Li Ming Li Yaoping Li Yunfeng Li Guole Lin Haiying Liu Ming Liu Qian Liu Zhizhong Pan Yifan Peng Niansong Qian Meng Qiu Li Ren Yueming Sun Jianqiang Tang Qingchao Tang Yuan Tang Kaixiong Tao Min Tao Haijiang Wang Meng Wang Zejun Wang Zhengguang Wang Ziqiang Wang Ziwei Wang Shaozhong Wei Baocai Xing Bin Xiong Ye Xu Su Yan Bin Yang Chunkang Yang Qinghua Yao Yingjiang Ye Ying Yuan Guozhi Zhang Haizeng Zhang Hongmei Zhang Zhen Zhang Yunshi Zhong Ji Zhu Yuan Zhu Yuping Zhu Shuangmei Zou Yuliuming Wang Jingfang Lv Enrui Liu Ming Yang Qian Zhang Weiyuan Zhang Lin Zhang Jun Luo Zhaoxu Zheng Zhixun Zhao Zheng Liu Jinhua Tao Haiyang Huang Tianli Chen Xishan Wang 不详 Department of Colorectal Cancer Surgery The Second Affiliated Hospital of Harbin Medical UniversityHarbinChina State key Laboratory of Cancer Biology National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive DiseasesFourth Military Medical UniversityXi’anChina Department of Gastrointestinal SurgeryⅢ Peking University Cancer HospitalBeijingChina Department of Gastrointestinal Surgery Peking University Shougang HospitalBeijingChina Department of Colorectal Surgery and Oncology(Key Laboratory of Cancer Prevention and Intervention China National Ministry of EducationKey Laboratory of Molecular Biology in Medical SciencesZhejiang Provincial Clinical Research Center for CANCER)The Second Affiliated HospitalZhejiang University School of MedicineHangzhouZhejiangChina Department of Gastrointestinal and Colorectal Surgery The China-Japan Union Hospital of Jilin University(The Third Hospital of Jilin University)ChangchunChina Department of Gastrointestinal Oncology Key laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing)Peking University Cancer Hospital&InstituteBeijingChina Gastrointestinal Department of The Third Affiliated Hospital of Shandong First Medical University TaianShandongChina Department of Colorectal Surgery Zhongshan Hospital Fudan UniversityShanghaiChina Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive Technology ShanghaiChina Zhongshan Hospital Xiamen University XiamenChina Department of Abdominal Oncology Surgery Ganzhou Cancer HospitalGanzhouJiangxiChina Fudan University Shanghai Cancer Center ShanghaiChina Department of colorectal surgery Sun Yat-sen University Cancer CenterGuangzhouChina Guangxi Medical University Cancer Hospital NanningChina Jilin Cancer Hospital ChangchunChina Department of Gastrointestinal Surgery the First Affiliated Hospital of Chongqing Medical UniversityChongqingChina Department of Colorectal Surgery Fujian Medical University Union HospitalFuzhou

Purpose Colorectal cancer is a common malignant tumor *** china,the ratio of rectal cancer to coloncancer in terms of incidence is close to 1:*** rectal cancer accounts for more than half of all cases of rectal *** recent years,the proportion of rectal cancer has trended downward,however the incidence of rectal cancer inyounger adults is *** CACA Guidelines for Holistic Integrative Management of Rectal Cancer were editedto help improve the diagnosis and comprehensive treatment in *** This guideline has been prepared by consensuses reached by the CACA Committee of Colorectal CancerSociety,based on a careful review of the latest evidence including china’s studies,and referred to domestic and internationalrelative guidelines,also considered china’s specific national conditions and clinical *** The CACA Guidelines for Holistic Integrative Management of Rectal Cancer include the epidemiology of rectalcancer,prevention and screening,diagnosis,treatment of nonmetastatic and metastatic rectal cancer,follow-up,and whole-course rehabilitation *** Committee of Colorectal Cancer Society,{3. Anti-Cancer Association,standardizes the diagnosisand treatment of rectal cancer in china through the formulation of the CACA Guidelines.

关键词： Rectal cancer Guideline Screening Diagnosis Treatment Rehabilitation management Holistic integrative medicine

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中国胰岛素泵院内护理质量控制专家共识

中华糖尿病杂志 2023年第9期15卷 804-813页

作者：赵芳张明霞邢秋玲袁丽陶静李彩宏李君李饶李阳溪王美君徐晶晶张宁董颖越莫永珍王群武全莹肖凌凤周莹霞万青袁红娣母义明郭立新陈莉明郭晓蕙肖新华尹士男中华护理学会糖尿病护理专业委员会中日友好医院内分泌科北京100029 北京大学人民医院内分泌科北京100044 天津医科大学朱宪彝纪念医院内分泌科天津300134 四川大学华西医院内分泌代谢科成都610041 华中科技大学同济医学院附属同济医院内分泌科武汉430030 北京清华长庚医院内分泌科北京102218 北京大学第一医院内分泌科北京100034 江苏省人民医院内分泌科南京210029 南京大学医学院附属鼓楼医院内分泌科南京210008 中国医学科学院北京协和医院内分泌科北京100730 江苏省省级机关医院内分泌科南京210009 北京大学第三医院内分泌科北京100191 北京医院内分泌科北京100730 济南市中心医院内分泌科济南250000 上海交通大学医学院附属瑞金医院内分泌代谢病科上海200025 华中科技大学同济医学院附属协和医院内分泌科武汉430022 浙江大学医学院附属邵逸夫医院内分泌科杭州310016 解放军总医院第一医学中心内分泌科北京100853 解放军总医院第一附属医院内分泌科北京100017 不详

随着我国糖尿病治疗需求的日益升高,胰岛素泵的使用大幅增加,特别是在医疗机构中已成为重要的血糖控制手段。为协助各级医疗机构及全院各科室保障胰岛素泵院内治疗效果及患者安全,提供胰岛素泵质量管理依据,中华护理学会糖尿病专业委员... 详细信息

随着我国糖尿病治疗需求的日益升高,胰岛素泵的使用大幅增加,特别是在医疗机构中已成为重要的血糖控制手段。为协助各级医疗机构及全院各科室保障胰岛素泵院内治疗效果及患者安全,提供胰岛素泵质量管理依据,中华护理学会糖尿病专业委员会组织该领域专家,撰写了《中国胰岛素泵院内护理质量控制专家共识》。该共识就院内胰岛素泵使用中的人员组织构架、制度、设备耗材、人员培训与考核、文件管理、置泵过程、健康教育、效果评价等各个质量管理环节均提供了细化指导。

关键词：胰岛素泵护理质量评价共识

在线全文

学校读者我要写书评

暂无评论

恶性肠梗阻的整合治疗

肿瘤代谢与营养电子杂志 2019年第4期6卷 421-426页

作者：石汉平陈永兵饶本强王昆华丛明华李苏宜陈俊强巴一束永前沈琳李薇陈子华江志伟刘明于世英中国抗癌协会肿瘤营养专业委员会首都医科大学附属北京世纪坛医院胃肠外科/临床营养科/肿瘤代谢与营养北京市国际科技合作基地/首都医科大学肿瘤学系北京100038 昆明医科大学第一附属医院胃肠与疝外科昆明650032 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院综合科北京100021 安徽医科大学附属省立医院肿瘤营养与代谢治疗科合肥230031 广西医科大学第一附属医院胃肠腺体外科南宁530021 天津医科大学肿瘤医院/国家肿瘤临床研究中心/天津市恶性肿瘤临床研究中心/天津市肿瘤防治重点实验室天津300060 南京医科大学第一附属医院肿瘤科南京210029 北京大学肿瘤医院消化肿瘤内科北京100142 吉林大学第一医院肿瘤中心长春130021 中南大学湘雅医院普外科长沙410008 南京军区南京总医院普通外科/全军普外研究所南京210002 哈尔滨医科大学附属第四医院普外科哈尔滨150001 华中科技大学同济医学院同济医院肿瘤中心武汉430030 不详

恶性肠梗阻(malignant bowel obstruction,MBO)是由恶性肿瘤导致的肠梗阻,最常见于卵巢、胃和结直肠肿瘤。MBO的病理生理与良性疾病所致的肠梗阻既有相似之处,也有显著不同,其治疗既遵循肠梗阻的一般原则,也遵循恶性肿瘤的一般原则。尽... 详细信息

恶性肠梗阻(malignant bowel obstruction,MBO)是由恶性肿瘤导致的肠梗阻,最常见于卵巢、胃和结直肠肿瘤。MBO的病理生理与良性疾病所致的肠梗阻既有相似之处,也有显著不同,其治疗既遵循肠梗阻的一般原则,也遵循恶性肿瘤的一般原则。尽管MBO总体预后差,但是MBO并非不治之症。MBO的治疗是一种整合疗法,包括如下11个方面:抑制分泌、制止呕药、抑制炎症、控制疼痛、抗击肿瘤、液体管理、促进排空、改善体能、减压引流、改善营养、肠腔再通。MBO目前没有一个适用于所有患者的金科玉律,也没有一把可以确切解决所有问题的万能钥匙。理想的MBO治疗只能是个体化基础上的综合治疗。组建跨专业的多学科MBO诊疗团队,制订平衡理想与现实的MBO诊疗规范,确立以解决主要矛盾——提高生活质量为导向的治疗目标,充分听取患者本人及亲属的意见,积极有效的综合治疗仍然可以显著改善肿瘤患者生活质量、延长生存时间。

关键词：肿瘤恶性肠梗阻综合治疗

Guidelines for Diagnosis and Treatment of Atopic Dermatitis in china(2020)#

在线全文

学校读者我要写书评

暂无评论

International Journal of Dermatology and Venereology 2021年第1期4卷 1-9页

作者： Xu Yao Zhi-Qiang Song Wei Li Yun-Sheng Liang Yan Zhao Hua Cao Tao Chen Xue Chen Ai-Ping Feng Song-Mei Geng Heng Gu Shu-Ping Guo Yan-Ling He Ye-Hong Kuang Chun-Ying Li Xiao-Hong Li Zheng-Xiao Li Jun-Qin Liang Hong-Ye Liu Ling-Ling Liu Yu-Mei Liu Zhi Liu Hai Long Qian-Jin Lu Yan Lu Xiao-Qun Luo Xiao-Yan Lv Lin Ma Zhu Shen Xin Shi Zhong-Xiang Shi Xiang-Yang Su Qing Sun Jian-Ping Tang Ao-Xue Wang Hui-Ping Wang Jian-Qin Wang Ming-Yue Wang Zai-Xing Wang Yu-Min Xia Ting Xiao Zhi-Qiang Xie Huan Xing Ying Xiong Zi-Gang Xu Bin Yang Zhi-Rong Yao Jian-Bin Yu Nan Yu Kang Zeng Jian-Zhong Zhang Jun-Ling Zhang Hua Zhao Zuo-Tao Zhao Wei Zhu Ying-Hua Zhu Ying Zou Atopic Dermatitis Working Group,Immunology Group,chinese Society of Dermatology Hospital for Skin Diseases(Institute of Dermatology) Chinese Academy of Medical SciencesNanjingJiangsu 210042China Southwest Hospital of Military Medical University Chongqing 400038China Huashan Hospital Affiliated with Fudan UniversityShanghai 200040China Dermatology Hospital of Southern Medical University GuangzhouGuangdong 510091China Peking University People’s Hospital Beijing 100044China Ruijin Hospital Affiliated with Shanghai Jiaotong UniversityShanghai 310000China Chengdu Second People’s Hospital ChengduSichuan 610017China Union Hospital Affiliated with Tongji Medical College of Huazhong University of science and Technology WuhanHubei 430022China The Second Affiliated Hospital of Xi’an Jiaotong University Xi’anShaanxi 710004China First Hospital of Shanxi Medical University TaiyuanShanxi 030012China beijing Chao-Yang Hospital Capital Medical UniversityBeijing 100027China Xiangya Hospital Central South UniversityChangshaHunan 410008China Xijing Hospital Fourth Military Medical UniversityXi’anShaanxi 710032China The First Affiliated Hospital of Zhengzhou University ZhengzhouHenan 450052China People’s Hospital of Xinjiang Uygur Autonomous Region WulumuqiXinjiang 830001China Peking University First Hospital Beijing 100034China Guangzhou Institute of Dermatology GuangzhouGuangdong 510095China The Affiliated Hospital of Guizhou Medical University GuiyangGuizhou 550004China The Second Xiangya Hospital of Central South University ChangshaHunan 410011China The First Affiliated Hospital of Nanjing Medical University NanjingJiangsu 210029China West china Hospital Sichuan UniversityChengduSichuan 610041China beijing Children’s Hospital Capital Medical UniversityBeijing 100045China Sichuan academy of Medical sciences&Sichuan Provincial People’s Hospital ChengduSichuan 610072China The Second Affiliated Hospital of Soochow University SuzhouJiangsu 215004China Shandong Provincial Dermatology Hospital JinanShandong 250022China The Third Affiliated Hospital of Sun Yat-sen U

Atopic dermatitis(AD)is a common disease clinically characterized by chronic recurrent eczematous lesions,dry skin,and *** can negatively impact patients’quality of *** prevalence of AD in china has been increasing during the past few *** on the most recent advances in the treatment of AD,we updated the 2014 version of the Guidelines for Diagnosis and Treatment of Atopic Dermatitis in china regarding the definition,epidemiology,pathogenesis,clinical classification,diagnosis,prevention,and treatment of AD.

关键词： atopic dermatitis diagnosis therapy guideline

Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in china: An Expert Consensus Statement (2021 Version)

在线全文

学校读者我要写书评

暂无评论

International Journal of Dermatology and Venereology 2021年第2期4卷 100-108页

作者： Hong Fang Xing-Hua Gao Song-Mei Geng Heng Gu Jun Gu Li He Xian Jiang Hong-Zhong Jin Qiang Ju Xiao-Jing Kang Wei Lai Cheng-Xin Li Hang Li Heng-Jin Li Shan-Shan Li Yu-Zhen Li Qing Sun Juan Tao Baoxi Wang Gang Wang Xin-Feng Wu Lei-Hong Xiang Hong-Fu Xie Hao-Xiang Xu Jin-Hua Xu Yan Yan Zhi-Zhong Zheng Department of Dermatology The First Affiliated Hospital of Zhejiang UniversityHangzhouZhejiang 310003China Department of Dermatology No.1 Hospital of China Medical UniversityShenyangLiaoning 110001China Department of Dermatology The Second Affiliated Hospital of Xi’an Jiaotong UniversityXi’anShaanxi 710061China Hospital for Skin Diseases(Institute of Dermatology) Chinese Academy of Medical Sciences and Peking Union Medical CollegeNanjingJiangsu 210042China Department of Dermatology Shanghai Tenth People’s HospitalTongji University School of MedicineShanghai 200072China Department of Dermatology First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China Department of Dermatology West China HospitalSichuan UniversityChengduSichuan 610041China Department of Dermatology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Department of Dermatology Renji HospitalSchool of MedicineShanghai Jiaotong UniversityShanghai 200025China Department of Dermatology People’s Hospital of Xinjiang Uygur Autonomous RegionUrumqiXinjiang 830001China Department of Dermatology and Venereology The Third Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdong 510630China Department of Dermatology First Medical Center of Chinese PLA General HospitalBeijing 100853China Department of Dermatology and Venerology Peking University First HospitalBeijing 100034China Department of Dermatology Hainan Hospital of PLA General HospitalSanyaHainan 572013China Department of Dermatology and Venereology The First Hospital of Jilin UniversityChangchunJilin 130021China Department of Dermatology Second Affiliated Hospital of Harbin Medical UniversityHarbinHeilongjiang 150086China Department of Dermatology Qilu Hospital of Shandong UniversityJinanShandong 250012China Department of Dermatology Affiliated Union HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhanHubei 430022China De

Acne inversa/hidradenitis suppurativa is a chronic,recurrent,inflammatory skin disease that affects the pilosebaceous units,causinfollicular *** etiology and pathogenesis of acne inversa/hidradenitis suppurativa involves internal and external factors such as genetic susceptibility,inflammation and immunity,microorganisms,obesity,and *** inversa/hidradenitis suppurativa is difficult to treat,and the current aim of treatment is to control the frequency and duration of disease flares and improve the quality of *** protocols for acne inversa/hidradenitis suppurativa should be selected based on the disease severity *** treatments include antibiotics,retinoids,biologics,immunosuppressive agents,and antiandrogen *** treatments include surgery and laser/light *** consensus aims to further standardize the diagnosis and treatment procedures of acne inversa/hidradenitis suppurativa in china to facilitate its diagnosis and treatment.

关键词： acne inversa consensus diagnosis hidradenitis suppurativa therapy

在线全文

学校读者我要写书评

暂无评论

非小细胞肺癌少见/罕见靶点:共识与争鸣

循证医学 2023年第3期23卷 129-139页

作者：吴一龙陆舜程颖周清涂海燕周清华王绿化张力周建英黄诚陈明胡成平揣少坤汪笑男刘晓晴刘基巍周鹏辉陈维之严令华刘云鹏刘安文张绪超李慧陈蓉蓉林冬梅谢聪颖朱正飞梁会营宋勇董晓荣赵明芳乔贵宾崔久嵬李子明王志杰陈晓媛杨农林根田攀文范云宋启斌陈元段建春王佳蕾朱波汪步海赵军于起涛王立峰张海波胡洁马锐张同梅林劼褚倩任胜祥姚煜邬麟王慧娟吴芳钟文昭胡毅陈克能赵健张力杨帆王群岳东升周建娅申鹏张嘉涛闫小龙黄媚娟冯卫能李力中国抗癌协会肺癌专业委员会广东省临床试验协会/中国胸部肿瘤研究协作组不详广东省肺癌研究所南方医科大学附属广东省人民医院(广东省医学科学院)广州510080 上海交通大学附属胸科医院上海200030 吉林省肿瘤医院长春130021 四川大学华西医院成都610041 中国医学科学院肿瘤医院深圳医院广东深圳518116 中山大学肿瘤防治中心广州510060 浙江大学医学院附属第一医院杭州310031 福建省肿瘤医院福州350011 中南大学湘雅医院长沙410008 广州燃石医学检验所有限公司广州510300 南京世和基因生物技术股份有限公司南京210032 解放军总医院北京100071 大连医科大学附属第一医院辽宁大连116011 无锡臻和生物科技有限公司江苏无锡214105 上海桐树生物科技有限公司上海200444 中国医科大学附属第一医院沈阳110001 南昌大学附属第二医院南昌330006 北京吉因加科技有限公司北京102206 北京大学肿瘤医院北京100142 温州医科大学附属第二医院浙江温州325027 复旦大学附属肿瘤医院上海200032 东部战区总医院南京210002 华中科技大学同济医学院附属协和医院武汉430022 吉林大学白求恩第一医院长春130021 中国医学科学院肿瘤医院北京100021 清华大学医学院北京100084 湖南省肿瘤医院长沙410013 中国科学院大学附属肿瘤医院/浙江省肿瘤医院杭州310022 武汉大学人民医院肿瘤中心武汉430060 华中科技大学同济医学院附属同济医院武汉430030 陆军军医大学第二附属医院-新桥医院重庆400037 南京大学医学院附属苏北人民医院江苏扬州225001 广西医科大学附属肿瘤医院南宁530012 南京大学医学院附属鼓楼医院南京210008 广东省中医院广州510120 复旦大学附属中山医院上海200032 辽宁省肿瘤医院沈阳110042 首都医科大学附属北京胸科医院北京101149 昆明医科大学第二附属医院昆明650101 同济大学附属上海市肺科医院上海200433 西安交通大学第一附属医院西安710061 郑州大学附属肿瘤医院/河南省肿瘤医院郑州450003 中南大学湘雅二医院长沙410011 广州医科大学附属肿瘤医院广州510095 北京协和医院北京100032 北京大学人民医院北京100044 天津医科大学肿瘤医院天津300060 南方医科大学南方医院广州510515 空军军医大学唐都医院西安710038 佛山市第一人民医院广东佛山528000 陆军军医大学大坪医院重庆400042

由中国抗癌协会肺癌专业委员会和广东省临床试验协会/中国胸部肿瘤研究协作组主办的“第20届中国肺癌高峰论坛”于2023.3.4日在广州顺利召开。此次论坛以非小细胞肺癌(non-small cell lung cancer,NSCLC)少见/罕见靶点为主题,从少见/... 详细信息

由中国抗癌协会肺癌专业委员会和广东省临床试验协会/中国胸部肿瘤研究协作组主办的“第20届中国肺癌高峰论坛”于2023.3.4日在广州顺利召开。此次论坛以非小细胞肺癌(non-small cell lung cancer,NSCLC)少见/罕见靶点为主题,从少见/罕见靶点的精准检测、新型临床研究与围术期治疗等角度开展相关学术探讨,并最终达成了专家共识。

关键词：非小细胞肺癌少见/罕见靶点共识争鸣